Benjamin L. Ebert, M.D., Ph.D., Dana-Farber Cancer Institute
Dr. Ebert discusses the revolution in the use of genetic testing in the clinical setting for the diagnosis and treatment decisions for bone marrow failure diseases. He explains the difference between germ-line and somatic mutations, the use of genetic testing for prognosis and response to therapy, and how genetic tests may identify pre-disposition to bone marrow failure
4 апр 2017